Touyun Biotech Group (HKSE:01332) COGS-to-Revenue : 0.77 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group COGS-to-Revenue?

Touyun Biotech Group's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$73.6 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$95.3 Mil.

Touyun Biotech Group's COGS to Revenue for the six months ended in Dec. 2023 was 0.77.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Touyun Biotech Group's Gross Margin % for the six months ended in Dec. 2023 was 22.75%.

Touyun Biotech Group COGS-to-Revenue Historical Data

The historical data trend for Touyun Biotech Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group COGS-to-Revenue Chart

Touyun Biotech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.63

0.59

0.62

0.72

Touyun Biotech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.62	0.65	0.59	0.66	0.77

Touyun Biotech Group COGS-to-Revenue Calculation

Touyun Biotech Group's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	142.036	/	198.64
	=	0.72

Touyun Biotech Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	73.599	/	95.273
	=	0.77

Touyun Biotech Group (HKSE:01332) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Touyun Biotech Group's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	73.599 / 95.273
	=	22.75 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Touyun Biotech Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group (HKSE:01332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines